Answer
Jun 23, 2026 - 11:05 AM
For Omnipod 5, published averages are usually around 6.8% to 7.4%, depending on the study population and starting A1C.
The best “average A1C on Omnipod 5” answer is: around 6.8–7.0% in type 1 clinical trials, and around 7.3–7.4% in broader real-world or type 2 populations. In the type 1 pivotal trial, adults/adolescents went from 7.16% to 6.78%, while children went from 7.67% to 6.99%.
People who start with a higher A1C often see bigger reductions. In a real-world study, overall A1C dropped by 0.4%, but users starting at A1C ≥9% dropped by 1.4% on average.
For type 2 diabetes, the SECURE-T2D trial reported average A1C improving from 8.2% to 7.4% after 13 weeks, with the subgroup starting at ≥9% improving from 10.1% to 8.1%.
A1C results still depend heavily on carb counting/meal boluses, CGM wear, pump settings, insulin sensitivity, missed boluses, and target settings, so your own result could be lower or higher than these averages.
| Group / Study | Average A1C Before | Average A1C After Omnipod 5 |
|---|---|---|
| Type 1 diabetes, adults/adolescents ages 14–70, pivotal trial | 7.16% | 6.78% |
| Type 1 diabetes, children ages 6–13.9, pivotal trial | 7.67% | 6.99% |
| Type 1 diabetes, preschool children ages 2–5.9 | 7.4% | 6.9% |
| Type 2 diabetes, SECURE-T2D pivotal trial | 8.2% | 7.4% |
| Real-world mixed T1D/T2D users | 7.8% | About 7.4% after a 0.4% average drop |
People who start with a higher A1C often see bigger reductions. In a real-world study, overall A1C dropped by 0.4%, but users starting at A1C ≥9% dropped by 1.4% on average.
For type 2 diabetes, the SECURE-T2D trial reported average A1C improving from 8.2% to 7.4% after 13 weeks, with the subgroup starting at ≥9% improving from 10.1% to 8.1%.
A1C results still depend heavily on carb counting/meal boluses, CGM wear, pump settings, insulin sensitivity, missed boluses, and target settings, so your own result could be lower or higher than these averages.
